Skip to content
HowShorted

Arcturus Therapeutics Holdings Inc. short interest in 2021

In 2021, Arcturus Therapeutics Holdings Inc.'s disclosed short interest ran from 13.96% of shares outstanding on 15 Jan 2021 to 8.93% on 31 Dec 2021, a change of -5.03 percentage points. The year's high was 19.60% on 14 May 2021 and its low 7.14% on 15 Oct 2021, averaging 12.26% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.37 days on 28 May 2021. Full history: Arcturus Therapeutics Holdings Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcturus Therapeutics Holdings Inc. in 2021

2021 in figures

Start of year
13.96% (15 Jan 2021)
End of year
8.93% (31 Dec 2021)
Change
-5.03 pp
High
19.60% (14 May 2021)
Low
7.14% (15 Oct 2021)
Average
12.26%
Highest days to cover
12.37 (28 May 2021)
SEC filings marked
8

Every report in 2021

Arcturus Therapeutics Holdings Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202113.96%1.21
29 Jan 202111.76%2.18
12 Feb 202110.57%3.20
26 Feb 202113.03%3.44
15 Mar 202112.94%3.9310-K filed, results (8-K)
31 Mar 202115.37%6.31
15 Apr 202116.58%8.43
30 Apr 202118.57%9.80
14 May 202119.60%8.1510-Q filed, results (8-K)
28 May 202119.04%12.37
15 Jun 202116.57%9.79
30 Jun 202115.21%6.57
15 Jul 202114.21%8.00
30 Jul 202113.98%11.31
13 Aug 20218.57%1.00results (8-K), 10-Q filed
31 Aug 20219.35%4.14
15 Sep 20217.98%4.51
30 Sep 20217.31%4.67
15 Oct 20217.14%4.33
29 Oct 20217.70%5.95
15 Nov 20218.46%3.24results (8-K), 10-Q filed
30 Nov 20219.47%4.43
15 Dec 20218.03%3.94
31 Dec 20218.93%2.51

See also: Arcturus Therapeutics Holdings Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.